Pharmaceutical pricing and reimbursement policies: perspectives for the future

被引:0
|
作者
Andrew L Gray
机构
[1] University of KwaZulu-Natal,Division of Pharmacology, Discipline of Pharmaceutical Sciences
关键词
Reference Price; Universal Health Coverage; Reimbursement Policy; Pharmaceutical Policy; Essential Medicine List;
D O I
10.1186/2052-3211-8-S1-K3
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Balancing medical innovation and affordability in the new healthcare ecosystem in China: Review of pharmaceutical pricing and reimbursement policies
    Chen, Vivian
    Shao, Wenbin
    HEALTH CARE SCIENCE, 2023, 2 (06): : 381 - 391
  • [22] Pharmaceutical policies:: effects of reference pricing, other pricing, and purchasing policies
    Aaserud, M.
    Dahlgren, A. T.
    Kosters, J. P.
    Oxman, A. D.
    Ramsay, C.
    Sturm, H.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (02):
  • [23] Orphan Drug Pricing and Reimbursement Policies Lacking in EU
    不详
    PHARMACEUTICAL MEDICINE, 2018, 32 (04) : 297 - 298
  • [24] Pharmaceutical pricing and managed entry agreements: An exploratory study on future perspectives in Europe
    Jommi, Claudio
    Bertolani, Arianna
    Armeni, Patrizio
    Costa, Francesco
    Otto, Monica
    HEALTH POLICY AND TECHNOLOGY, 2023, 12 (03)
  • [25] Pharmaceutical Pricing and Reimbursement Information (PPRI): a European Union project
    Arts, Danielle
    Habl, Claudia
    Rosian, Ingrid
    Vogler, Sabine
    EPIDEMIOLOGY BIOSTATISTICS AND PUBLIC HEALTH, 2006, 3 (01): : 36 - 40
  • [26] Market Distributions and Pricing/Reimbursement Policies of Antihypertensive Drugs in Turkiye
    Tengiz, Istemihan
    Atila, Dincer
    Ercan, Ertugrul
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2023, 51 (05): : 299 - 303
  • [27] Pricing policies for the pharmaceutical market - An international perspective
    Ilgin, Y
    Eisen, R
    VALUE IN HEALTH, 2005, 8 (06) : A184 - A184
  • [28] A framework for assessing the impact of pharmaceutical reimbursement policies on incentives to innovate
    Elizabeth Docteur
    Joshua Cohen
    Brian K Bruen
    Ruth Lopert
    Avi Dor
    Chuck Shih
    Journal of Pharmaceutical Policy and Practice, 8 (Suppl 1)
  • [29] Comparison of pharmaceutical pricing and reimbursement systems in Turkey and certain EU countries
    Atikeler, Enver Kagan
    Ozcelikay, Gulbin
    SPRINGERPLUS, 2016, 5
  • [30] Stakeholder preferences about policy objectives and measures of pharmaceutical pricing and reimbursement
    Vogler, Sabine
    Zimmermann, Nina
    Habimana, Katharina
    HEALTH POLICY AND TECHNOLOGY, 2016, 5 (03) : 213 - 225